Repurposing Azoles to Resolve Serotogenic Toxicity Associated with Linezolid to Combat Multidrug-Resistant Tuberculosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposing Azoles to Resolve Serotogenic Toxicity Associated with Linezolid to Combat Multidrug-Resistant Tuberculosis
Authors
Keywords
-
Journal
ACS Medicinal Chemistry Letters
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2023-11-01
DOI
10.1021/acsmedchemlett.3c00406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bioisosteric modification of Linezolid identified the potential M. tuberculosis protein synthesis inhibitors to overcome the myelosuppression and serotonergic toxicity associated with Linezolid in the treatment of the multi-drug resistance tuberculosis (MDR-TB)
- (2023) Rukaiyya Girase et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade
- (2023) Khushbu Sharma et al. ACS Omega
- Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective
- (2022) Frederic Lamoth et al. CLINICAL INFECTIOUS DISEASES
- Antifungals in Clinical Use and the Pipeline
- (2021) Melissa D. Johnson INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- An overview of drug discovery and development
- (2020) Nurken Berdigaliyev et al. Future Medicinal Chemistry
- Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis
- (2020) Hongyi Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
- (2017) Belén R. Imperiale et al. REVISTA ARGENTINA DE MICROBIOLOGIA
- Rifampicin-Resistance Mutations in the rpoB Gene in Bacillus velezensis CC09 have Pleiotropic Effects
- (2017) Xun-Chao Cai et al. Frontiers in Microbiology
- Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index
- (2016) Sean Wasserman et al. Expert Review of Anti-Infective Therapy
- Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis
- (2016) V. R. Bollela et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Linezolid Induced Adverse Drug Reactions - An Update
- (2015) Kamal Kishor et al. CURRENT DRUG METABOLISM
- Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives
- (2015) Pradeep Jadhavar et al. CURRENT MEDICINAL CHEMISTRY
- Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates
- (2013) G. Brandis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibacterial oxazolidinones: emerging structure–toxicity relationships
- (2010) Adam R Renslo Expert Review of Anti-Infective Therapy
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More